These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2482790)

  • 41. Successful use of granulocyte-macrophage colony-stimulating factor in patients with acute lymphocytic leukemia.
    Smith T; Grossberg H
    Am J Med; 1990 Sep; 89(3):384-6. PubMed ID: 2203265
    [No Abstract]   [Full Text] [Related]  

  • 42. Differential effect of GM-CSF and G-CSF in cyclic neutropenia.
    Freund MR; Luft S; Schöber C; Heussner P; Schrezenmaier H; Porzsolt F; Welte K
    Lancet; 1990 Aug; 336(8710):313. PubMed ID: 1695985
    [No Abstract]   [Full Text] [Related]  

  • 43. Nursing care of AIDS patients participating in a Phase I/II trial of recombinant human granulocyte-macrophage colony stimulating factor.
    Lynch M; Yanes L; Todd K
    Oncol Nurs Forum; 1988; 15(4):463-9. PubMed ID: 3041383
    [No Abstract]   [Full Text] [Related]  

  • 44. Granulocyte macrophage colony stimulating factor (GM-CSF) current status and future development.
    Bonnem EM; Morstyn G
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):46-51. PubMed ID: 3057644
    [No Abstract]   [Full Text] [Related]  

  • 45. [GM-CSF: its use in onco-hematologic diseases].
    Visani G; Tosi P; Benfenati D; Colombini R; Cenacchi AR; Gamberi B; Lemoli RM; Tura S
    Haematologica; 1989 Oct; 74(5 Suppl):501-10. PubMed ID: 2512232
    [No Abstract]   [Full Text] [Related]  

  • 46. Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma.
    Gianni AM; Bregni M; Siena S; Orazi A; Stern AC; Gandola L; Bonadonna G
    J Clin Oncol; 1990 May; 8(5):768-78. PubMed ID: 2185337
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy.
    Lieschke GJ; Maher D; Cebon J; O'Connor M; Green M; Sheridan W; Boyd A; Rallings M; Bonnem E; Metcalf D
    Ann Intern Med; 1989 Mar; 110(5):357-64. PubMed ID: 2644886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acceleration of autologous hematopoietic recovery by GM-CSF after allograft rejection.
    Bandini G; Rosti G; Cavo M; Albertazzi L; Tura S
    Haematologica; 1989; 74(6):627-8. PubMed ID: 2697676
    [No Abstract]   [Full Text] [Related]  

  • 49. [Agranulocytosis treatment with rhGM-CSF].
    Rosien U; Benker G; Brittinger G; Reinwein D
    Dtsch Med Wochenschr; 1989 Nov; 114(47):1861. PubMed ID: 2684585
    [No Abstract]   [Full Text] [Related]  

  • 50. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.
    Neta R; Oppenheim JJ; Douches SD
    J Immunol; 1988 Jan; 140(1):108-11. PubMed ID: 2447166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of treatment with rhGM-CSF and low-dose cytosine arabinoside on leukemic blast cells in patients with myelodysplastic syndromes.
    Hoelzer D; Ganser A; Ottmann OG; Höffken K; Becher R; Lutz D; Krieger O; Diehl V; Lathan B; Boogaerts MA
    Haematol Blood Transfus; 1990; 33():763-9. PubMed ID: 2182466
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of neutropenia associated with dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor.
    Russo CL; Glader BE; Israel RJ; Galasso F
    Lancet; 1990 Sep; 336(8717):751-2. PubMed ID: 1975922
    [No Abstract]   [Full Text] [Related]  

  • 53. GM-CSF expands the eosinophilic compartment in chronic idiopathic neutropenia.
    Andersson R; Elgefors B; Ridell B; Gisslén M; Kutti J
    Eur J Haematol; 1990 May; 44(5):315-6. PubMed ID: 2196184
    [No Abstract]   [Full Text] [Related]  

  • 54. [GM-CSF: its clinical administration; the treatment of aplasia].
    Rossi Ferrini P; Grossi A; Santini V; Vannucchi AM
    Haematologica; 1989 Oct; 74(5 Suppl):489-500. PubMed ID: 2512231
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical applications of colony-stimulating factors.
    Groopman JE
    Semin Oncol; 1988 Dec; 15(6 Suppl 6):27-33. PubMed ID: 2462748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor.
    Vadhan-Raj S; Buescher S; Broxmeyer HE; LeMaistre A; Lepe-Zuniga JL; Ventura G; Jeha S; Horwitz LJ; Trujillo JM; Gillis S
    N Engl J Med; 1988 Dec; 319(25):1628-34. PubMed ID: 3059191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy.
    Herrmann F; Schulz G; Wieser M; Kolbe K; Nicolay U; Noack M; Lindemann A; Mertelsmann R
    Am J Med; 1990 Jun; 88(6):619-24. PubMed ID: 2189305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Expectations in the clinical application of human-recombinant cytokines. 4) Interleukin-3 and colony-stimulation factors].
    Takaku F
    Nihon Rinsho; 1988 May; 46(5):1105-11. PubMed ID: 2457722
    [No Abstract]   [Full Text] [Related]  

  • 59. Damage control.
    Beardsley TM
    Sci Am; 1988 Apr; 258(4):32, 36. PubMed ID: 2459771
    [No Abstract]   [Full Text] [Related]  

  • 60. [Cytokines in clinical use].
    Meyer P; Wilms K
    Internist (Berl); 1988 Nov; 29(11):717-26. PubMed ID: 2466805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.